 |
|
|
|
|
|
|
|
 |
Results for 'Roche: PharmaVitae Profile 2005' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Roche Partnering Guide 2008
|
July 2021 |
£195 |
35 % |
Analgesics in the United Kingdom
|
August 2006 |
£450 |
29.05 % |
Eye Care in the United Kingdom
|
August 2006 |
£450 |
29.05 % |
Wound Treatments in the United Kingdom
|
August 2006 |
£450 |
29.05 % |
Digestive Remedies in the United Kingdom
|
August 2006 |
£450 |
28.35 % |
Vitamins and Dietary Supplements in the United Kingdom
|
August 2006 |
£450 |
28 % |
NRT Smoking Cessation Aids in the United Kingdom
|
August 2006 |
£450 |
28 % |
Medicated Skin Care in the United Kingdom
|
August 2006 |
£450 |
27.65 % |
Analgesics in Spain
|
July 2006 |
£450 |
27.3 % |
Eye Care in Spain
|
July 2006 |
£450 |
27.3 % |
Wound Treatments in Spain
|
July 2006 |
£450 |
27.3 % |
NRT Smoking Cessation Aids in Spain
|
July 2006 |
£450 |
26.6 % |
Digestive Remedies in Spain
|
July 2006 |
£450 |
26.6 % |
Cough, Cold and Allergy (Hay Fever) Remedies in the United Kingdom
|
August 2006 |
£450 |
26.6 % |
Vitamins and Dietary Supplements in Spain
|
July 2006 |
£450 |
26.6 % |
Medicated Skin Care in Spain
|
July 2006 |
£450 |
26.25 % |
Cancer Market Trends 2006 - 2010
Key market forecasts and growth opportunities
|
December 2006 |
£1050 |
25.2 % |
Cough, Cold and Allergy (Hay Fever) Remedies in Spain
|
July 2006 |
£450 |
25.2 % |
Innovative And Targeted Cancer Therapies
Key Technologies, New Applications And Leading Players
|
July 2007 |
£1545 |
22.75 % |
Obesity Drug Discoveries: what the future holds
|
August 2007 |
£1425 |
20 % |
Zimbabwe Pharmaceuticals and Healthcare Report Q3 2008
|
September 2008 |
£425 |
19.25 % |
Bigpharma Dealmaking Handbook
Companies & Contacts
|
September 2001 |
£2195 |
18.2 % |
United States Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2012
|
September 2008 |
£1060 |
17.85 % |
United States Diabetes Care Devices Medical Equipment Industry Report
Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Glucose Monitoring and Insulin Delivery Devices, Equipment and Supplies
|
April 2008 |
£990 |
17.15 % |
Partnering with Biopharma
The definitive guide to bigpharma partnering interests, contacts & agreements
|
July 2001 |
£1495 |
16.8 % |
Russian Pharma Sector Analysis (2007)
|
August 2007 |
£715 |
16.8 % |
Brazil Pharmaceuticals & Healthcare Report Q3 2006
|
July 2006 |
£395 |
16.5 % |
Pharmaceutical Product Approval Trends, 2007
Key Market Benchmarks And Strategic Insights
|
December 2007 |
£1299 |
16.45 % |
India In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012
|
October 2008 |
£1955 |
16.45 % |
Bigpharma Dealmaking and Agreements Handbook 2007
Companies, Contacts & Partnering Agreements
|
September 2007 |
£1195 |
16.1 % |
Pharmaceutical Market Trends, 2007-2011
Key market forecasts and growth opportunities (2nd Edition)
|
November 2007 |
£995 |
15.75 % |
Canada Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
June 2008 |
£990 |
15.4 % |
Belgium Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
June 2008 |
£990 |
15.4 % |
The Future of Monoclonal Antibodies Therapeutics
Innovation in antibody engineering, key growth strategies and forecasts to 2011
|
July 2006 |
£1495 |
15.05 % |
China In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012
|
October 2008 |
£1955 |
15.05 % |
Innovations in Diagnostics
|
September 2006 |
£1495 |
14.7 % |
Canada Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2012
|
September 2008 |
£1060 |
14.7 % |
Pharmaceutical Markets in Brazil, Russia, India and China (Bric Nations)
|
July 2008 |
£1150 |
14.35 % |
Australia Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
October 2008 |
£1955 |
14.35 % |
United States in Vitro Diagnostics Industry Report
Detailed Analysis of The Medical Equipment & Medical Devices Market Covering Clinical Chemistry, Immunochemistry, Infectious Immunology, Microbiology, Genetic and Blood Test Reagents, Insturments and Test Kits
|
May 2008 |
£1955 |
14.35 % |
Booming Clinical Trials Market in India
|
November 2007 |
£780 |
14 % |
Spain Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
October 2008 |
£1955 |
14 % |
United States Pharmaceuticals and Healthcare Report Q3 2006
|
July 2006 |
£395 |
13.5 % |
Japan Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
October 2008 |
£1955 |
13.3 % |
Licensing Strategies - Examining Todays Pharmaceutical Licensing Trends
|
November 2007 |
£7600 |
12.95 % |
Canada In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012
|
September 2008 |
£1095 |
12.6 % |
Mexico Pharmaceuticals and Healthcare Report Q3 2008
|
July 2008 |
£425 |
12.6 % |
Germany Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012
|
August 2008 |
£1045 |
12.6 % |
China Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2012
|
August 2008 |
£1045 |
12.6 % |
Stakeholder Opinions: Small Cell Lung Cancer and Malignant Mesothelioma
Limited R&D activity provides opportunity for early-phase pipeline drugs
|
March 2007 |
£2005 |
12.25 % |
Clinical Trials Market 2006, The
|
February 2006 |
£1499 |
12.25 % |
The Global Antivirals Market
R&D Pipelines, Market Analysis and Competitive Landscape
|
May 2007 |
£1630 |
12.25 % |
Belgium Diabetes Care Devices Investment Opportunities
Analysis and Forecasts to 2012
|
November 2008 |
£1955 |
12.25 % |
Netherlands Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to
|
November 2008 |
£1310 |
11.9 % |
Global Biotech Report 2006, The
The rise of the Biotech blockbusters
|
September 2006 |
£4999 |
11.9 % |
Medical Devices & Equipments In India
|
January 2007 |
£400 |
11.55 % |
Point of Care Diagnostics
|
February 2006 |
£3160 |
11.55 % |
Mexico Pharmaceuticals & Healthcare
|
December 2006 |
£395 |
11.2 % |
Global Diabetes Market; The
Therapeutics, Diagnostics and Complications
|
August 2006 |
£1630 |
10.85 % |
Clinica's Indian Market Briefing
|
January 2006 |
£500 |
10.5 % |
World Biotech Market 2005, The
|
June 2005 |
£4999 |
10.15 % |
U.S. and Worldwide Monoclonal Antibody Medicine
Current Status and Future Trends
|
August 2008 |
£715 |
9.8 % |
Monoclonal Antibody Therapies
Evolving into a $30 billion market
|
April 2005 |
£8000 |
9.8 % |
Commercial and Pipeline Insight: Hepatitis B
|
October 2007 |
£7600 |
9.45 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
9.45 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
9.45 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
9.45 % |
Dr. Reddy's Market Outlook, Forecasts and Analysis to 2012
|
April 2007 |
£1499 |
9.45 % |
Pharmaceutical Project and Portfolio Management
Effective organization and decision-making for long-term growth
|
January 2005 |
£1495 |
8.75 % |
Fastest Growing Biotechnology Companies, The
Growth Strategies, Comparative Analyses and Company Profiles
|
March 2008 |
£1995 |
8.4 % |
CNS Drug Discoveries
What the Future Holds
|
November 2006 |
£1995 |
8.05 % |
Pipeline/Commercial Insight: Supportive Care in Oncology
Significant growth opportunities exist in new supportive care indications
|
June 2007 |
£7600 |
8.05 % |
The Dynamic Media, Sera and Reagent Market in Biotechnology
|
March 2007 |
£3160 |
7.35 % |
Stakeholder Opinions: Primary Brain Cancer
Temozolomide Turns Heads
|
July 2007 |
£2005 |
7.35 % |
Stakeholder Insight: Non-Small Cell Lung Cancer
The need for greater product differentiation in an increasingly crowded market
|
November 2006 |
£8000 |
5.95 % |
PAREXEL's Bio/Pharma R&D Statistical Sourcebook 2008/2009
|
June 2008 |
£275 |
4.9 % |
Parexel's Pharmaceutical R&D Statistical Sourcebook 2007/2008
|
May 2007 |
£275 |
4.9 % |
Blood Banking and Blood products
|
March 2008 |
£2575 |
4.55 % |
Epigenomics
Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics
|
March 2007 |
£3160 |
4.2 % |
The Executive Guide to Molecular Imaging
|
July 2007 |
£595 |
3.15 % |
|
|
|
|
